Interview with Dr Richard W Barker, Director General, Association of the British…
Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place last…
Address: Innovation House
70 Norden Road
Maidenhead
Berkshire SL6 4AY
United Kingdom
Tel: +44 1628 501000
Web: http://www.biogenidec.co.uk/
Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. We are the world’s oldest independent biotechnology company and a Fortune 500 company with more than $5 billion in revenues. Patients worldwide benefit from our products.
That’s one perspective on Biogen Idec, though it is not the only one.
To our patients, we are the trusted source of vital therapies for multiple sclerosis. We also discovered one of the world’s most prescribed treatments for non-Hodgkin’s lymphoma and an effective treatment for rheumatoid arthritis. Our patients count on us not only for medications, but also for a variety of support programs that help them deal with the rigors of living with serious illness.
To our employees, we are an exciting and invigorating place to work, an ambitious and nimble company where courageous innovation is encouraged and expected — not just of scientists but of every employee. Our manufacturing people take pride in our leadership in producing biologics, with more than 100,000 liters of capacity spread across three facilities. Our customer service representatives handle more than 800,000 calls per year, offering straightforward information, assistance and patient services. Across the company, in marketing, sales, quality control and human resources, people are empowered to challenge conventional wisdom and propose better ways of doing things.
To our partners and investors, we are a profitable company with a rich and diverse pipeline. We have the resources, financial strength and vision to successfully discover, develop, manufacture and commercialize new products.
And to our friends, neighbors and the world at large, we are a responsible corporate citizen with robust programs that make our communities better places to live and work and address critical issues like diversity and sustainability.
Biogen Idec is all these companies. We are dedicated to serving all our constituents, because Biogen Idec is in business to make a difference for all those we serve.
Biogen Idec’s products and development strategies cover a wide field of key medical issues. With regard to different therapeutic options, Biogen Idec has its focus on the areas of neurology and inflammatory diseases.
Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place last…
It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic Capability Clusters are just some…
As part of a panel discussion with Claudia Hammond of the BBC last year, you commented on the fairly poor relationship between the NHS and industry, and the need to…
Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw the great emergence of the generic…
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from close by. From your…
Given the heated debate over NHS reform and the new revised bill proposed by the government, what are you current priorities as President of the ABPI and how have these…
See our Cookie Privacy Policy Here